GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.

According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like ...

Preoperative glucagon-like peptide-1 receptor agonist use is not associated with short-term postoperative aspiration pneumonia.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

"This finding suggests that it may be beneficial to reassess the preoperative withholding guidelines for GLP-1 RAs." HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 ...

Three studies attempting to tease out the potential effects of glucagon-like peptide 1 receptor agonists (GLP-1 RA) taken before or during pregnancy were presented at the annual meeting of the ...

“Some metabolic supplements, often dubbed ‘faux-zempic,’ are marketed to mimic GLP-1 medications, though their mechanisms and ... some similarities [to GLP-1 RA medications] in that it ...

The first reason is because the mechanism of action [MOA] of using ... the company in a short amount of 12-weeks already proved that its GLP-1 RA MET-097i already attained a mean placebo adjusted ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with type 2 diabetes is linked to a reduced risk of developing certain hematologic cancers compared to insulin and metformin.

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...